PMID- 37015158 OWN - NLM STAT- MEDLINE DCOM- 20230425 LR - 20230425 IS - 1878-1705 (Electronic) IS - 1567-5769 (Linking) VI - 118 DP - 2023 May TI - Human umbilical cord-derived mesenchymal stem cells-harvested mitochondrial transplantation improved motor function in TBI models through rescuing neuronal cells from apoptosis and alleviating astrogliosis and microglia activation. PG - 110106 LID - S1567-5769(23)00427-7 [pii] LID - 10.1016/j.intimp.2023.110106 [doi] AB - Each year, traumatic brain injury (TBI) causes a high rate of mortality throughout the world and those who survive have lasting disabilities. Given that the brain is a particularly dynamic organ with a high energy consumption rate, the inefficiency of current TBI treatment options highlights the necessity of repairing damaged brain tissue at the cellular and molecular levels, which according to research is aggravated due to ATP deficiency and reactive oxygen species surplus. Taking into account that mitochondria contribute to generating energy and controlling cellular stress, mitochondrial transplantation as a new treatment approach has lately reduced complications in a number of diseases by supplying healthy and functional mitochondria to the damaged tissue. For this reason, in this study, we used this technique to transplant human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)-derived mitochondria as a suitable source for mitochondrial isolation into rat models of TBI to examine its therapeutic benefit and the results showed that the successful mitochondrial internalisation in the neuronal cells significantly reduced the number of brain cells undergoing apoptosis, alleviated astrogliosis and microglia activation, retained normal brain morphology and cytoarchitecture, and improved sensorimotor functions in a rat model of TBI. These data indicate that human umbilical cord-derived mesenchymal stem cells-isolated mitochondrial transplantation improves motor function in a rat model of TBI via rescuing neuronal cells from apoptosis and alleviating astrogliosis and microglia activation, maybe as a result of restoring the lost mitochondrial content. CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Bamshad, Chia AU - Bamshad C AD - Department of Medical Biotechnology, Faculty of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran. FAU - Habibi Roudkenar, Mehryar AU - Habibi Roudkenar M AD - Burn and Regenerative Medicine Research Center, Velayat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. FAU - Abedinzade, Mahmoud AU - Abedinzade M AD - Department of Operation Room, Faculty of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran. FAU - Yousefzadeh Chabok, Shahrokh AU - Yousefzadeh Chabok S AD - Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Iran. FAU - Pourmohammadi-Bejarpasi, Zahra AU - Pourmohammadi-Bejarpasi Z AD - Burn and Regenerative Medicine Research Center, Velayat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. FAU - Najafi-Ghalehlou, Nima AU - Najafi-Ghalehlou N AD - Department of Medical Laboratory Sciences, Faculty of Paramedicine, Tabriz University of Medical Sciences, Tabriz, Iran. FAU - Sato, Tomoaki AU - Sato T AD - Department of Applied Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. FAU - Tomita, Kazuo AU - Tomita K AD - Department of Applied Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. FAU - Jahanian-Najafabadi, Ali AU - Jahanian-Najafabadi A AD - Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran. FAU - Feizkhah, Alireza AU - Feizkhah A AD - Burn and Regenerative Medicine Research Center, Velayat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. FAU - Mohammadi Roushandeh, Amaneh AU - Mohammadi Roushandeh A AD - Burn and Regenerative Medicine Research Center, Velayat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. Electronic address: mohammadi_roushandeh@gums.ac.ir. LA - eng PT - Journal Article DEP - 20230402 PL - Netherlands TA - Int Immunopharmacol JT - International immunopharmacology JID - 100965259 SB - IM MH - Humans MH - Rats MH - Animals MH - Gliosis MH - Microglia MH - *Mesenchymal Stem Cell Transplantation MH - *Brain Injuries, Traumatic MH - Mitochondria MH - Apoptosis/physiology MH - *Mesenchymal Stem Cells MH - Umbilical Cord OTO - NOTNLM OT - Apoptosis OT - Mesenchymal stem cells OT - Mitochondrial transplantation OT - Sensorimotor behaviour OT - Traumatic brain injury COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/04/05 06:00 MHDA- 2023/04/25 06:42 CRDT- 2023/04/04 18:00 PHST- 2022/11/12 00:00 [received] PHST- 2023/02/09 00:00 [revised] PHST- 2023/03/24 00:00 [accepted] PHST- 2023/04/25 06:42 [medline] PHST- 2023/04/05 06:00 [pubmed] PHST- 2023/04/04 18:00 [entrez] AID - S1567-5769(23)00427-7 [pii] AID - 10.1016/j.intimp.2023.110106 [doi] PST - ppublish SO - Int Immunopharmacol. 2023 May;118:110106. doi: 10.1016/j.intimp.2023.110106. Epub 2023 Apr 2.